Your browser doesn't support javascript.
loading
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.
Hanna, Glenn J; Rettig, Eleni M; Park, Jong C; Varvares, Mark A; Lorch, Jochen H; Margalit, Danielle N; Schoenfeld, Jonathan D; Tishler, Roy B; Goguen, Laura A; Annino, Donald J; Haddad, Robert I; Uppaluri, Ravindra.
Afiliação
  • Hanna GJ; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA. Electronic address: glenn_hanna@dfci.harvard.edu.
  • Rettig EM; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, Boston, MA.
  • Park JC; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston, MA.
  • Varvares MA; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston, MA; Massachusetts Eye & Ear Infirmary, Boston, MA.
  • Lorch JH; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA.
  • Margalit DN; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Radiation Oncology, Brigham & Women's Hospital, Boston, MA.
  • Schoenfeld JD; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Radiation Oncology, Brigham & Women's Hospital, Boston, MA.
  • Tishler RB; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Radiation Oncology, Brigham & Women's Hospital, Boston, MA.
  • Goguen LA; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, Boston, MA.
  • Annino DJ; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, Boston, MA.
  • Haddad RI; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA.
  • Uppaluri R; Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, Boston, MA.
Oral Oncol ; 112: 105087, 2021 01.
Article em En | MEDLINE | ID: mdl-33190021
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / SARS-CoV-2 / COVID-19 / Neoplasias de Cabeça e Pescoço / Hospitalização Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oral Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / SARS-CoV-2 / COVID-19 / Neoplasias de Cabeça e Pescoço / Hospitalização Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oral Oncol Ano de publicação: 2021 Tipo de documento: Article